Biomeme
PrivateLast Round
VC Round
Dec 20, 2021
Total Funding Raised
$5.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Biomeme operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a VC Round in December 2021.
Biomeme is a diagnostic equipment company that manufactures a mobile platform for real-time DNA and RNA testing outside of traditional laboratory settings.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Defense Tech, Environmental Monitoring, Biotech Equipment
Business Model
B2G
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomeme Comparables
Compare Biomeme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveo Technologies | 86% | |
| Coyote Bioscience Co., Ltd. | 83% | |
| Novel Microdevices | 82% |
For institutional investors. Book with your work email.
Biomeme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 20, 2021 | ||||
| Grant | Nov 30, 2021 | ||||
| Grant | Apr 9, 2021 | ||||
| VC Round | Mar 1, 2020 | ||||
| Seed | Jan 29, 2014 | ||||
Accelerator | Aug 9, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biomeme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Defense Health Agency | Grant |
| Benjamin Franklin Technology Partners | Seed, VC Round |
| Bundesministerium für Bildung und Forschung | VC Round |
| Dreamit Ventures | Seed, Accelerator |
| Foundation for Innovative New Diagnostics | VC Round |
| Commonwealth of Pennsylvania | Grant |
| Independence Blue Cross | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 60% MoM, from 6.4K to 10.3K.
- Jul 25, 2026
Monthly visitors increased 33% MoM, reaching 6.4K.
For institutional investors. Book with your work email.
Biomeme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biomeme's valuation, stock price, and market status.
Is Biomeme a public or private company?
Biomeme is a private company.
What is the current stock price of Biomeme?
Biomeme is a private company, so its shares have no public market price. Caplight tracks Biomeme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biomeme worth (valuation)?
Valuation information for Biomeme is not publicly available.
Can I buy Biomeme stock?
Biomeme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biomeme's last funding round?
Biomeme's most recent funding round was VC Round on December 20, 2021.
Who are the main investors in Biomeme?
Key investors in Biomeme include Defense Health Agency, Benjamin Franklin Technology Partners, Dreamit Ventures, Foundation for Innovative New Diagnostics, Commonwealth of Pennsylvania.
Will Biomeme IPO soon?
No public IPO plans have been announced for Biomeme.
How can I track Biomeme secondary market activity?
Caplight tracks bids, offers, and trades in Biomeme's shares on secondary markets.